https://www.bmj.com/content/376/bmj.o102

"Today, despite the global rollout of covid-19 vaccines and treatments, the anonymised participant level data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public--and are likely to remain that way for years to come. This is morally indefensible for all trials, but especially for those involving major public health interventions."